Weight regain is common if eating habits revert to pre-treatment patterns
But how does it stack up against other methods, and is it the right choice for you
In these cases, consistent medical guidance is required to ensure the therapy supports ongoing health management effectively
Across SURMOUNT-1 and -2, treatment discontinuation due to an AE occurred in 4.8%, 6.3% and 6.7% of patients receiving tirzepatide 5 mg, 10 mg and 15 mg, respectively and 3.4% of patients receiving placebo
La competencia de la estadounidense Eli Lilly , las limitaciones de suministro y la presin sobre los precios han enfriado el nimo, mientras que los nuevos aranceles de EE.UU
GLP-1 can decrease cardiomyocyte destruction and increase cell viability after ischemiareperfusion injury 17